In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Biofrontera and Kiadis agree to merge; withdrawn

Executive Summary

Biofrontera Pharmaceuticals GMBH (drug discovery for nervous system disorders) and Kiadis BV (identifies biologically active compounds) have agreed on a merger of equals. They plan to continue to operate in their respective locations as wholly owned subsidiaries of a new holding company, Aliga Pharmaceuticals AG.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
      • Molecular Diversity
        • Natural Products
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies

UsernamePublicRestriction

Register